Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001979170 | SCV002223472 | pathogenic | Fanconi anemia | 2022-01-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser333*) in the FANCI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCI are known to be pathogenic (PMID: 17452773, 17460694). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FANCI-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002484717 | SCV002802713 | likely pathogenic | Fanconi anemia complementation group I | 2021-08-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002484717 | SCV004199189 | likely pathogenic | Fanconi anemia complementation group I | 2023-10-25 | criteria provided, single submitter | clinical testing |